Skip to content

Efficacy and safety of Tai Chi for rehabilitation after PCI in patients with coronary heart disease: A protocol of a randomized controlled trial

Efficacy and safety of Tai Chi for rehabilitation after PCI in patients with coronary heart disease: A protocol of a randomized controlled trial

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230101002
Enrollment
68
Registered
2023-01-01
Start date
2023-01-22
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease (CHD) is a common cardiovascular disease. In clinical practice, percutaneous coronary intervention (PCI) can improve myocardial blood perfusion and save the lives of patients with CHD, but there are still problems such as restenosis or chest pain after PCI. As a traditional Chinese exercise, Tai Chi has a positive effect on cardiac rehabilitation. However, there is a lack of rigorous clinical studies to evaluate the efficacy and safety of Tai Chi for rehabilitation after P

Interventions

The treatment group will be combined with Tai Chi exercise on the basis of the treatment regimen in the control group. Professional rehabilitation physicians will guide patients to perform Tai Chi exe
Experimental Other

Sponsors

Huaying Wang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnosis of angina pectoris in CHD, and meet coronary angiography or coronary angiography showed at least one coronary artery stenosis and catheter stenosis no less than 50%, cardiac MRI or radionuclide myocardial perfusion imaging confirmed myocardial ischemia and ECG ST-T changes in patients with CHD; (2) Stable condition after surgical treatment with PCI; (3) Aged no less than 18 years, and be not more than 70 years, regardless of gender; (4) limb joint activity is normal, can complete Tai Chi exercise; (5) Patients voluntarily participate in the trial and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severe cardiopulmonary diseases such as dissection of aortic, severe aortic coarctation, aortic aneurysm, pulmonary embolism, pulmonary infarction; (2) Patients with severe cardiac arrhythmia; (3) Patients with severe liver and kidney dysfunction and severe hematopoietic system abnormalities, water electrolyte abnormalities and other diseases; (4) Patients with severe mental illness who have difficulty cooperating; (5) Pregnant or lactating women; (6) Patients with uncontrolled infectious or non-infectious inflammatory diseases; (7) Patients who cannot perform this exercise after professional evaluation; (8) Subjects who are participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
Seattle Angina Questionnaire 24 weeks Five dimensions: the degree of restriction of physical activity, angina pectoris stable state, frequency of angina pectoris attack, satisfaction with treatment, and awareness of the disease.

Secondary

MeasureTime frame
Cardiac function indicators 24 weeks left ventricular ejection fraction (LVEF) was measured by color doppler ultrasonic diagnostic apparatus

Countries

China

Contacts

Public ContactPengcheng Ren

The People's Hospital of Dazu,Chongqing,China

doctorr@163.com15696122469

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026